Otsuka Novel Products GmbH clinical trials

A country office of Otsuka Holdings Co., Ltd.

The registry lists 1 studies whose lead sponsor is Otsuka Novel Products GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2015.

Status

Terminated: 1

Phase

Phase 2: 1
Phase 1: 1

Where

United Kingdom: 1

Registry sponsor names on this page

Otsuka Novel Products GmbH1 study

Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Otsuka Holdings Co., Ltd. studies →

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerTerminatedNCT02042885Phase 1/2
Sponsor listed in the registry: Otsuka Novel Products GmbH